New Zealand has taken the reasonable and sensible step to ban the prescribing of harmful, experimental drugs to children suffering gender distress. This brings them into line with most western and developed nations such as the UK and Nordic countries. Puberty blockers are being used off label, causing catastrophic harm to a generation of youth who have been lied to and told they could have been born in the wrong body. The ultimate cruelty is these confused children have been given drugs designed as chemical castration drugs issued to violent criminals and also as a treatment for prostate cancer. The effects of the harmful drugs rob children of the human right to mature from children to adulthood intact. They create lifelong pharmaceutical consumers who rely on many more drugs to counter the negative impacts, while in most cases not curing the initial gender distress. Once these children realise they have been lied to and do not in fact change sex, the impact on their lives is devastating.
New Zealand Minister for Health, Simeon Brown MP has posted an explanation regarding the decision to stop new patients being given the drugs on X. Cabinet has agreed to restrict the prescribing of puberty blockers for patients seeking treatment for gender dysphoria or incongruence. When it comes to children’s health, clinical evidence must guide decisions to ensure any medicine given to young Kiwis is proven, safe and effective. The independent Cass Review, commissioned by the UK’s NHS, identified considerable uncertainty about the long-term safety and clinical effectiveness of hormone-suppressing treatments for gender dysphoria or incongruence. This wasn’t a political review, it was clinical. New Zealand’s own Ministry of Health reached the same conclusions in November 2024. Its evidence brief found significant limitations in the quality of evidence regarding both benefits and risks when hormone-suppressing treatments are used for the treatment of gender dysphoria or incongruence.
While this uncertainty persists, the Government is taking a precautionary approach. Governments across the political spectrum are reaching the same evidence-based conclusions. The UK, Sweden, Finland, and Norway have all implemented similar safeguards while evidence is gathered. Last year, the UK Labor Government announced that the NHS would stop routine use of hormone-suppressing treatments for gender dysphoria or incongruence outside of clinical research settings while the NHS establishes a rigorous clinical trial to properly understand their effects. Back home, Cabinet has decided to align our approach with the UK, waiting for this clinical evidence before reconsidering any decisions. Cabinet has agreed to restrict the prescribing of hormone-suppressing treatment for new patients seeking treatment for gender dysphoria or incongruence until we have better evidence. Hormone-suppressing treatments remain fully available for other medical conditions like early-onset puberty, endometriosis, and prostate cancer, where clinical evidence clearly demonstrates their benefit.
Our government expects that existing youth gender support services will continue to support young people and their families. Cabinet has put in place stronger safeguards so families can have confidence that any treatment is clinically sound and in the best interests of the child. Here in Australia our government is too cowardly or conniving to do the same thing. They know what the debate and data will reveal. Labor and the Greens continually block any motions or bills that would act to safeguard vulnerable children. They know full well there is no evidence to support the false narrative a child was born in the wrong body. Australian politicians who support experimenting on children and robbing them of healthy development are regressive and dangerous. We are one of the last countries in the world to persist with the harmful “affirmation” model. We must continue to advocate for these vulnerable youth and highlight the lies and deception our government has engaged in.
Source: Binary
Print This Post
Comments are closed